video1.0<iframe src="https://www.loom.com/embed/97cb875d4bae46639e130fd46d5efea7" frameborder="0" width="1920" height="1440" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>14401920Loomhttps://www.loom.com14401920https://cdn.loom.com/sessions/thumbnails/97cb875d4bae46639e130fd46d5efea7-465b484be1395923.gif3551.6This Loom shares an alumni conversation about the Nucleate Activator program and how to turn early life science into a biotech venture. Co-founders from Alveda Biosciences and Animal Bio discuss misconceptions about glycans and endometriosis models, how they applied to Activator, and what typical weekly engagement looks like. They emphasize choosing a clear focus, prioritizing next de-risking experiments to reach inflection points, and using mentorship to refine investor-ready storytelling, including therapeutic versus diagnostic priorities. Alumni also describe team matching options and recommend deeper networking with founders, mentors, and leadership. The Loom concludes with program overview metrics including 2,000 applications, 180 finalist teams, 17 regions, and outcomes such as 300 plus alumni companies raising 650 million USD and creating 900 jobs.